18 Hrs
Source:
الشارقة 24
UAE Approves Memrylo for Erythromelalgia
The Emirates Foundation for Medicine has approved the use of "Memrilor" (Ruxolitinib) for the treatment of adults with polycythemia vera, a rare blood disorder characterized by excessive production of red blood cells. This approval, the second worldwide, represents an important step in providing advanced treatment options for patients with this condition, which can lead to increased blood viscosity and a higher risk of blood clots. "Memrilor" helps to lower red blood cell levels and effectively manage the condition, thereby enhancing patients' quality of life and reflecting the Foundation's commitment to offering modern and reliable therapies.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)